ADA Scientific Sessions 2025 Abstract

Novel Oral Small Molecule ACCG-2671—A Dual Amylin and Calcitonin Receptor Agonist Development Candidate for Obesity Therapy

By Xiankang Fang, Z. Zhang, Haizhen Zhang, Fang Zhang

Experiments in animalsInterventions

The paper

San Francisco

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, late-breaking 2184-LB

doi.org/10.2337/db25-2184-lb

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity